Experiences with an new MRSA management regime in the clinic combine southwest;Erfahrungen mit einem neuen MRSA-management im klinikverbund südwest

Hygiene + Medizin

Volumn 35, Issue 9, 2010, Pages 306-314

  Rünz, Thilo ^a   Volbracht, Jörk ^a   Weiß, Gunther ^a   Kellner, Miriam ^a  

^a Sindelfingen Böblingen Hospital   (Germany)

Author keywords

Combined swab; Hospital information system; Hospital acquired infection; Hygieneorder; MRSA; PCR; Screening

Indexed keywords

EID: 79955756137     PISSN: 01723790     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Nationales Referenzzentrum für Surveillance, KISS. Krankenhaus-Infektions-Surveillance-System: Modul MRSA-KISS, Referenzdaten, Berechnungszeitraum 01.01.2007-31.12.2007. 2008.
2. Nationales Referenzzentrum für Surveillance, KISS. Krankenhaus-Infektions-Surveillance-System: Modul MRSA-KISS, Referenzdaten, Berechnungszeitraum 01.01.2008-31.12.2008. 2009.
3. Nationales Referenzzentrum für Surveillance, KISS. Krankenhaus-Infektions-Surveillance-System: Modul MRSA-KISS, Referenzdaten, Berechnungszeitraum 01.01.2009-31.12.2009. 2010.
4. Robert Koch-Institut, Mitteilung der Kommission für Krankenhaushygiene und Infektionsprävention sowie des Robert. Kommentar zu den "Empfehlungen zur Prävention und Kontrolle von MRSA-Stämmen in Krankenhäusern und anderen medizinischen Einrichtungen". Epidemiologisches Bulletin. 2008, Bd. Nr. 42, S. 363-364.
5. Schulz M, Nonnenmacher C., Mutters R. Costeffectiveness of rapid MRSA screening in surgical patients. Eur J Clin Microbiol Infect Dis. 2009;28:1291-1296.
6. Kunori T, Cookson B, Roberts JA, Stone S, Kibbler C. Cost-effectiveness of different MRSA screening methods. J Hosp Infect. 2002;51(3):189-200. (Pubitemid 38001891)
7. Batra R., Eziefula A. C., Wyncoll D., Edgeworth J. Throat and rectal swabs may have an important role in MRSA screening of critically ill patients. Intensive Care Med. 2008;34:1703-1706.
8. Robert Koch-Insitut. Zum Management des MRSA-Screenings. Epidemiologisches Bulletin. 2005, 42.
9. Reick, Doris. Persönliche Mitteilung. [Hrsg.] Landesgesundheitsamt Baden-Württemberg. 2010.
10. Clancy M, Graepler A, Wilson M, Douglas I, Johnson J, Price CS. Active screening in high-risk units is an effective and cost-avoidant method to reduce the rate of methicillin-resistant Staphylococcus aureus infection in the hospital. Infect Control Hosp Epidemiol. 2006;27(10):1009-1017. (Pubitemid 44670975)
11. Eveillard M, Lancien E, Barnaud G, Hidri N, Gaba S, Benlolo JA, Joly-Guillou ML. Impact of screening for MRSA carriers at hospital admission on risk-adjusted indicators according to the imported MRSA colonization pressure. J Hosp Infect. 2005;59(3):254-258. (Pubitemid 40197789)
12. Harbarth S, Fankhauser C, Schrenzel J, Christenson J, Gervaz P, Bandiera-Clerc C, Renzi G, Vernaz N, Sax H, Pittet D. Universal screening for methicillinresistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. JAMA 2008;299(10):1149-1157. (Pubitemid 351398429)
13. Wernitz MH, Swidsinski S, Weist K, Sohr D, Witte W, Franke KP, Roloff D, Rüden H, Veit SK. Effectiveness of a hospital-wide selective screening programme for methicillin-resistant Staphylococcus aureus carriers at hospital admission to prevent hospitalacqired MRSA infections. Clin Microbiol Infect. 2005;11:457-465. (Pubitemid 40744392)
14. McConeghy KW, Mikolich DJ, Laplante KL. Agents for the Decolonization of Methicillin-Resistant Staphylococcus aureus. Pharmacotherapy 2009;29(3):263-280.
15. Sandri AM, Dalarosa MG, De Alcântara LR, Da Silva EL, Zavascki AP, Sandri AM, Dalarosa MG, De Alcântara LR, Da Silva EL, Zavascki AP. Reduction in incidence of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection in an intensive care unit: Role of treatment with mupirocin ointment and chlorhexidine baths for nasal carriers of MRSA. Infect Control Hosp Epidemiol. 2006;27(2):185-187. (Pubitemid 43384766)
16. Simor AE, Phillips E, McGeer A, Konvalinka A, Loeb M, Devlin HR, Kiss A. Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus colonization. Clinical Infectious Diseases 2007;44(N2):127-135.
17. Curran E, Harper P, Loveday H, Gilmour H, Jones S, Benneyan J, Hood J, Pratt R. Results of a multicentre randomised controlled trial of statistical process control charts and structured diagnostic tools to reduce ward-acquired meticillin-resistant Staphylococcus aureus: the CHART Project. J Hosp Infect. 2008;70(2):127-135.
18. Gastmeier, P. Reduktion nosokomialer Infektionen durch Surveillance: Nationale Referenzdaten durch das Krankenhaus-Infektions-Surveillance-System. 2005;102(30):A-2098.
19. Deutsches Ärzteblatt 2005;102(30):A-2098.
20. Keshtgar MR, Khalili A, Coen PG, Carder C, Macrae B, Jeanes A, Folan P, Baker D, Wren M, Wilson AP. Impact of rapid molecular screening for meticillinresistant Staphylococcus aureus in surgical wards. Br J Surg. 2008;95(3):381-386.
21. Wernitz MH, Keck S, Swidsinski S, Schulz S, Veit SK. Cost analysis of a hopital-wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers in the context of diagnosis related groups (DRG) payment. Clin Microbiol Infect. 2005;11(6):466-471. (Pubitemid 40744393)